Urovalve
Newsroom
Urovalve

Newsroom

Back to newsroom

Incubator Seed Fund Award Recipients

The Commission voted on May 19, 2006 in a public meeting to award Incubator Seed Fund Grants to the following:

Urovalve, Inc. at the NJIT Enterprise Development Center in Newark $44,231
The purpose of Urovalve, Inc. is to design, develop, and commercialize superior medical devices that address problems with urinary flow and control. Three specific areas of interest are urinary retention; leakage (incontinence), and diagnostics (urodynamics). The current focus of the Company is on completing development, regulatory approval and commercialization of our initial device; a disposable, patient-controlled intraurethral valved-catheter that is intended to treat chronic male urinary retention (such as that caused by spinal cord injury and neurological diseases) and acute male urinary retention (such as that caused by prostate hypertrophy). Urovalve has developed technology to control fluid flow through small diameter flexible tubing.